Could SUVmax be an auxiliary parameter in the clinical management of pulmonary hydatid disease?-Reference-Cited by-同舟云学术

Could SUVmax be an auxiliary parameter in the clinical management of pulmonary hydatid disease?

Author:

Ozmen Ozlem¹^ORCID,Tatci Ebru¹,Uslu Biner Inci¹,Findik Gokturk²,Yilmaz Ulku³,Erturk Hakan⁴,Demirag Funda⁵

Affiliation:

1. Department of Nuclear Medicine; Ataturk Chest Diseases and Thoracic Surgery Training and Research Hospital; Ankara Turkey

2. Department of Chest Surgery; Ataturk Chest Diseases and Thoracic Surgery Training and Research Hospital; Ankara Turkey

3. Department of Chest Diseases; Ataturk Chest Diseases and Thoracic Surgery Training and Research Hospital; Ankara Turkey

4. Department of Radiology; Ataturk Chest Diseases and Thoracic Surgery Training and Research Hospital; Ankara Turkey

5. Department of Pathology; Ataturk Chest Diseases and Thoracic Surgery Training and Research Hospital; Ankara Turkey

Publisher

Wiley

Subject

Genetics(clinical),Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

Reference20 articles.

1. Treatment of liver hydatid disease with mebendazole: a prospective study of thirteen cases;Gil-Grande;Am J Gastroenterol,1983

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献